Investors

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Oct 20, 2020
Document Date
Oct 19, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Neoleukin Therapeutics, Inc.
Issuer
Neoleukin Therapeutics, Inc.
Filer
VANCE HOLLY